Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TAMIVIVE

Financiado

Cerrado

Tools and methods for in vivo electroporation

Electroporation (EP) is the phenomenon in which cell membrane permeability to molecules is increased after exposing the cell to high electric field short pulses. Depending on various factors, such permeabilization will be temporar... ver más

30/06/2014

UPF

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

UNIVERSITAT POMPEU FABRA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 323

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-06-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UPF

0.00€ | Lider

Proyectos interesantes

TEC2014-52383-C3-2-R

Medical Technol...

Biotechnology

67K€ Cerrado

NANOEP

Medical Technol...

Nanotechnology

100K€ Cerrado

TEC2010-17285

Medical Technol...

Biotechnology

100K€ Cerrado

E-DNA-T-PEP

Medical Technol...

Nanotechnology

1M€ Cerrado

GETPolPhys

Medical Technol...

Applied Physics

150K€ Cerrado

RYC-2009-04271

Medical Technol...

Biomedical Imag...

192K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITAT POMPEU FABRA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 323

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Electroporation (EP) is the phenomenon in which cell membrane permeability to molecules is increased after exposing the cell to high electric field short pulses. Depending on various factors, such permeabilization will be temporary and will not compromise cell viability ("reversible EP") or will be permanent, or too intense, so that homeostasis will be severely disrupted and the cell will end up dying by necrotic or apoptotic processes ("irreversible EP"). Both EP modes have important applications in biotechnology and in medicine. For instance, reversible EP is now a routine technique in microbiology labs for in vitro DNA transfection. My interest in EP was stimulated during my postdoctoral position at the University of California at Berkeley (2005-2009). There I had the opportunity to participate in the process in which Prof. Rubinsky brought the concept of using irreversible EP as an ablation technique from a mere idea into a clinical reality. In May 2009 I moved to Prof. Mir's lab at Villejuif (France) as a preliminary step in order to reintegrate myself into the EP European research arena. During the 90s, Prof. Mir pioneered the use of EP for enhancing the penetration of anti-tumor drugs. Control over the field magnitude that develops in tissues is crucial for EP therapies. During my postdoctoral position I introduced a set of techniques for such a purpose based on the concept of employing conductive gels. Feasibility of this method was demonstrated experimentally in superficial tumors and I anticipate that this methodology could be also useful for the treatment of different cancers, particularly those located in hollow organs such as esophagus, stomach and colon, which in some occasions are inoperable with current techniques. One specific objective of the project will be to explore in depth this opportunity. The other objectives are also related to in vivo EP applications. Numerical simulations and in vitro models will be used as research tools.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores